Headlines

Bank of Baroda registrations 2026 underway for managerial positions: Check direct link to register and other details here
42 minutes ago
Moody’s projects India’s GDP to grow 6.4% in FY’27, fastest among G20 economies
43 minutes ago
Police arrest 2 teens in US Capitol shooting of 15-year-old victim
45 minutes ago
Oil Prices Decline As Supply Worries Ease
48 minutes ago
2026 Winter Olympics: Lindsey Vonn breaks leg in downhill crash, in stable condition at hospital
49 minutes ago
Art Nirman Limited
54 minutes ago

HEALTH & LIFE STYLE

Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’

varam1 month ago02 mins mins

Danaher is finally turning the corner. CNBC’s Jim Cramer sees it. Wall Street does, too. The life sciences stock is “ready to go for a romp” after years of “nightmare” performance, Cramer said during Friday’s December Monthly Meeting for Investing Club members. Danaher — which makes tools and technologies used by pharmaceutical, biotech, and medical device firms — has faced a tough few years after Covid. The company’s business was also pressured by China’s policy changes aimed at mitigating health care costs in the world’s second-largest economy. But that’s changing. Wells Fargo analysts are the latest to recognize Danaher’s recovery — raising their price target to $240 per share from from $230, implying 6% upside from Friday’s $226 close. Wells Fargo kept its hold-equivalent equaly weight rating. For 2026, the analysts are forecasting a modest organic growth acceleration in the life science tools industry due to improved biopharma spending. They also noted stabilizing academic and government demand, particularly in the United States. Analysts over at Bank of America also boosted Danaher’s price target, going to $265 from $250. They said that industry “headwinds are expected to fade and markets are expected to normalize after a myriad of persistent challenges.” Last week, Goldman Sachs initiated coverage of the life-sciences tools group, starting Dahaner with a buy rating and a $265 price target. The analysts see organic revenue growth of 9.2% in 2026 compared to the consensus expectation of about 6.1% growth. Two weeks ago, Morgan Stanley started Danaher with a buy-equivalent rating and named it a top pick. Earlier this month, Cramer used Agilent Technologies to illustrate the resurgence in life sciences. On Friday, Cramer said he has made no secret of his disappointment over Danaher in the past, which was still modestly lower for 2025, during a year when the S & P 500 has gained roughly 16%. However, the strong recovery in Danaher shares since their late September lows cannot be denied. The stock gained nearly 25% during that stretch. “After spending time in the wilderness of the $180 level, I think that a lot of people feel like they’re glad to get out alive,” Cramer said. “That’s wrong.” With the stock trading in $220s now, Cramer told Club members Friday that it’s actually “a fine time to buy some Danaher, and an even finer time if it goes lower.” Danaher was one of seven out-of-favor stocks that Cramer identified as buys during the Club’s December meeting.

SleepLean – Improve Sleep & Support Healthy Weight

Source link

👉 Visit the Official SleepLean Website

Discover more from stock updates now

Subscribe to get the latest posts sent to your email.

Check SleepLean Official Website

Trending News

EDUCATION

Business

Category Collection

Bank of Baroda registrations 2026 underway for managerial positions: Check direct link to register and other details here

Moody’s projects India’s GDP to grow 6.4% in FY’27, fastest among G20 economies

Police arrest 2 teens in US Capitol shooting of 15-year-old victim

Oil Prices Decline As Supply Worries Ease

2026 Winter Olympics: Lindsey Vonn breaks leg in downhill crash, in stable condition at hospital

Art Nirman Limited

Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’

Like this:

Related

Discover more from stock updates now

Leave a ReplyCancel reply

Trending News

Category Collection

Share this:

Like this:

Related

Discover more from stock updates now

Leave a ReplyCancel reply

Related News